More Cures for More Patients: Overcoming Pharmaceutical Barriers

February 05, 2020

Testimony
Testimony by CFR fellows and experts before Congress.

Mr. Setser's testimony focuses on three points:

1. America currently has a large and growing trade deficit in pharmaceutical products.

More on:

Trade

Pharmaceuticals and Vaccines

Fiscal Policy

2. The Tax Cuts and Jobs Act created new incentives for the offshoring of pharmaceutical production and other high technology manufacturing jobs. As I will discuss later, the biggest sources of pharmaceutical imports are not countries known for low wages, but rather countries known for their high tolerance of transfer pricing games and generous tax treatment of multinational firms.

3. The Tax Cut and Jobs Act provided a large windfall to the shareholders of pharmaceutical firms who had shifted their profits and often production abroad to reduce their U.S. tax burden—but it hasn’t generated lower prices for American consumers or a significant increase in investment in pharmaceutical research and development. The work of the Ways and Means committee staff1 has illustrated that Americans pay by far the world’s highest prices for drugs. Yet today, Americans are getting far too little back from our biggest pharmaceutical companies.

More on:

Trade

Pharmaceuticals and Vaccines

Fiscal Policy

Top Stories on CFR

United States

The nuclear arms race was perhaps the most alarming feature of the Cold War competition between the United States and Soviet Union. Over the decades, the two sides signed various arms control agreements as a means to manage their rivalry and limit the risk of nuclear war. However, deep fissures have reemerged in the U.S.-Russia relationship in recent years, raising once again the specter of a nuclear arms race.

Haiti

U.S. Foreign Policy

U.S. interests argue for maintaining ties to Saudi Arabia despite clear evidence that the Crown Prince approved the murder of Jamal Khashoggi.